The Association of OLFM4 with the Progression and Cisplatin Resistance of Head and Neck Squamous Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly prevalent malignant tumor globally with a poor prognosis. Despite continuous advancements in treatment modalities, the molecular mechanisms underlying its progression and chemotherapy resistance remain unclear. In previous studies, cisplatin...
Saved in:
| Main Authors: | Xinlu He, Xi Yao, Keling Pang, Xulin Chen, Zhengbo Wei, Ying Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/5/276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
by: Devleena, et al.
Published: (2010-03-01) -
In vitro assay identifying cisplatin resistance of head and neck squamous cell carcinoma
by: Shu-Jen Chiang, et al.
Published: (2023-09-01) -
Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma
by: Ankit P. Jain, et al.
Published: (2024-12-01) -
Reserpine alleviates cisplatin-induced acute kidney injury via anti-ferroptosis and cGAS/STING pathway
by: Nahua Xu, et al.
Published: (2024-12-01) -
Inhibition of TPI1 Sensitizes Cisplatin-Resistant Oral Cancer to Ferroptosis
by: Dandan Wang, et al.
Published: (2025-05-01)